Abstract: Enteropathogenic Yersinia expresses several invasins that are fundamental virulence factors required for adherence and colonization of tissues in the host. Within the invasin-family of Yersinia adhesins, to date only Invasin has been extensively studied at both structural and functional levels. In this work, we structurally characterize the recently identified inverse autotransporter InvasinE from Yersinia pseudotuberculosis (formerly InvasinD from Yersinia pseudotuberculosis strain IP31758) that belongs to the invasin-family of proteins. The sequence of the C-terminal adhesion domain of InvasinE differs significantly from that of other members of the Yersinia invasinfamily and its detailed cellular and molecular function remains elusive. In this work, we present the 1.7 Å crystal structure of the adhesion domain of InvasinE along with two Immunoglobulin-like domains. The structure reveals a rod shaped architecture, confirmed by small angle X-ray scattering in solution. The adhesion domain exhibits strong structural similarities to the C-type lectin-like domain of Yersinia pseudotuberculosis Invasin and enteropathogenic/enterohemorrhagic E. coli Intimin. However, despite the overall structural similarity, the C-type lectin-like domain in InvasinE lacks motifs required for Ca 21 /carbohydrate binding as well as sequence or structural features critical for Tir binding in Intimin and b 1 -integrin binding in Invasin, suggesting that InvasinE targets a distinct, yet unidentified molecule on the host-cell surface. Although the biological role and target molecule of InvasinE remain to be elucidated, our structural data provide novel insights into the architecture of invasin-family proteins and a platform for further studies towards unraveling the function of InvasinE in the context of infection and host colonization.
Introduction
Of the Gram-negative genus Yersinia, three species are pathogenic to humans. The species Y. pestis is responsible for the plague, and the two enteropathogenic species Y. enterocolitica and Y. pseudotuberculosis are responsible for various gastrointestinal diseases that are sometimes followed by autoimmune disorders. 1 Y. pseudotuberculosis and Y. enterocolitica pathogenesis begins with bacterial adherence to epithelial cells followed by host cell invasion and colonization of host tissues. Here, the adhesin protein Invasin (InvA) is required by enteropathogenic Yersinia species to promote entry into the host cell. 2 After translocation across the epithelial barrier, Yersinia is exposed to a variety of immune cells such as dendritic cells, macrophages and lymphocytes. As defense mechanism, Yersinia injects several Yop (Yersinia outer proteins) into immune cells to modulate host cell signaling and counter early innate immune response, providing resistance against phagocytosis. Further, proteins like YadA (Yersinia adhesin A) and Ail (Adherence and Invasion Locus) provide resistance against complement-mediated lysis. Yersinia therefore utilizes various virulence factors to promote infection and support extracellular survival of the pathogen (reviewed in 3, 4 ).
Multiple adhesins of the invasin family are presented on the bacterial surface of Y. pseudotuberculosis that are expressed at different stages and conditions, allowing the bacteria to interact with a variety of different host substrates at different stages of the infection process. Invasins are members of the inverse autotransporter (IAT) family also referred to as type Ve secretion system. They consist of an Nterminal b-barrel-like domain, which is responsible for attachment of invasin to the outer membrane region of bacteria, repetitive Immunoglobulin-like (Ig) domains, which vary significantly in number among all the invasins, and the C-terminal domain/adhesion domain (AD), which provides invasins with the specificity to bind to its host target molecules. 5 Despite similarities in their architecture, invasins display considerable variety in terms of their sequence, structure and function. InvA is the best characterized invasin of Y. pseudotuberculosis so far [6] [7] [8] [ Fig. 1(A,B) ].
Besides InvA, two additional invasins are known, InvasinB (InvB) and InvasinC (InvC), that mediate binding to intestinal cells. 9 In addition to these three invasins, two novel invasins, InvasinD variant from strain IP31758 and InvasinD (InvD) variant from strain YPIII of Y. pseudotuberculosis, have recently been identified [ Fig. 1 (A), Supporting Information Fig. S1 ]. While these have been identified as members of the invasin-family by a sequence-based approach, the structure and function of both still remains elusive. The first 1730 amino acids (aa) of InvD Y. pseudotuberculosis IP31758, corresponding to the predicted b-barrel-like domain and bacterial Immunoglobulin-like (BIg) domains, are homologous to InvD from Y. pseudotuberculosis YPIII. But the Cterminal domain only shares 7-8% of sequence identity (12-17% similarity) with the C-terminal domains of InvA-C, and the sequence identity between InvD from strain IP31758 and InvD from YPIII is only 10% (similarity 17%). Thus, the sequence of the C-terminal domain of InvD from strain IP31758 is significantly different to any of the four invasins 9 [ Fig. 1(C) , Supporting Information Fig. S1 ]. Because of this significant difference in the C-terminal domain, which in adhesins typically represents the adhesion domain and mediates interaction with the host molecules, InvD Y. pseudotuberculosis IP31758 will hereafter be referred to as InvasinE (InvE), a novel sub-type within the members of the invasin-family. BLAST search for proteins sharing the sequence of the adhesion domain of InvE only identified presence of the domain with 100% sequence identity in Y. pseudotuberculosis, as well as in the species Y. wautersii and Y. similis of the genus Yersinia. A highly similar protein with a sequence identity of 89% for the adhesion domain has been further identified in Y. pestis. The structural and molecular basis of how InvE is involved in Yersinia pathogenesis is completely unknown. In this study, we thus aim to structurally characterize this recently identified invasin. Here, we present the crystal structure of InvE-AD with two BIg domains at 1.7 Å resolution along with the analysis in solution by small angle X-ray scattering (SAXS). InvE-AD adopts a C-type lectin-like domain (CTLD) fold with unique modifications. CTLDs not only bind to carbohydrates, but have been reported to also bind to proteins or inorganic lipids raising the question of the host derived target molecule of InvE. 10 After structure determination of InvA, 7 the first high-resolution structure of InvE presented here will increase our knowledge of the diverse invasins of Yersinia, and will contribute to our understanding of the role of InvE in their host system during infection. In addition, as a protein of a pathogenic Yersinia species, it represents an interesting drug-target for the future development of preventive therapies against Yersinia infections. 
Results

InvE domain architecture
InvE structure determination
Initial crystals obtained with InvE2448 only showed weak diffraction. To improve crystal quality, we applied a strategy of mutating surface entropic residues to enhance crystallization. 11 Based on this concept, four different mutants were cloned. These constructs include single mutants (K2646A and E2648A) and double mutants (E2505A/Q2506A and E2695A/K2696A). Out of these four constructs, we purified and successfully crystallized InvE2448 (K2646A) mutant, which yielded high quality diffraction data to 1.7 Å resolution. We initially attempted to determine the structure using molecular replacement with the BIg domains of InvA 7 as search models, but the approach was not successful. Therefore, a Selenomethionine variant of InvE2448 (K2646A) was expressed, purified and crystallized. Phasing was successful using single wavelength anomalous diffraction (SAD) and the structure was determined to 1.7 Å resolution using native data [ Fig. 3 (A-C), Supporting Information S2, Table I ].
InvE2448 crystallized in space group P2 1 with one molecule in the asymmetric unit. The overall structure of the construct is rod-like and displays a three domain architecture in which the domains BIg20 (2448-2546) and BIg21 (2547-2660) share an Immunoglobulin-like b-sandwich fold, while the AD (2661-2795) is a globular, a/b-domain [ Fig. 3(A,B) ].
We have further confirmed the rod shaped architecture of InvE in solution by SAXS. The chi value of the fit to the scattering data using InvE2448 structure as model equals 1.87, and the model is in very good agreement with the calculated SAXS-envelope [ Fig. 3(B,D) ].
The BIg20 and BIg21 domains
Analysis based on the primary sequence shows that BIg1-20 domains of InvE share high sequence identity in the range of 56-98% (sequence similarity 68-100%) while BIg21 is significantly different from BIg1-20 (sequence identity 15-18%; sequence similarity 31-36%) (Supporting Information Fig. S3 ).
This figure also includes an iMolecules 3D interactive version that can be accessed via the link at the bottom of this figure's caption. Despite the lower sequence identity between BIg20 and BIg21, both domains adopt a two layer bsandwich fold resembling eukaryotic members of Immunoglobulin-superfamily (IgSF) 12 [ Fig Table SI ]. In case of BIg20, these residues are located mainly on A'-B-E-F inter-strand loops, while residues mediating the contact with BIg20 are mainly clustered on the B-C interstrand loop. While these interactions appear to be sufficient to maintain the rod-like arrangement of InvE as seen in the SAXS data, the rather small interface area is likely to allow for a minor degree of flexibility, in agreement with the degradation seen in the proteolysis assay where cleavage is taking place at the BIg20-BIg21 junction (Supporting Information Fig. S5 ). In BIg20 of InvE, b-strands ABED form one sheet while the second b-sheet is formed by A'GFC. Presence of the A-A' strand with a kink formed by a cis-Proline (P2641), lack of C'' and presence of D strand is characteristic of the I1 set of IgSF. Even though BIg20 lacks strand C', we propose to classify BIg20 as I1 set, as lack of C' has also been observed previously in other I1 set domains. 13 Furthermore, two highly conserved Cysteine residues forming a disulfide-bridge in the canonical Ig-fold, here represented by an Ig-domain of the neural cell adhesion molecule (NCAM), 14 In BIg21, the first sheet is formed by ABE strands while the second sheet is formed by A'GFC. This type of fold can be categorized in the I2-set of where F obs and F calc are the observed and calculated structure factors, respectively. R free is the same as R work , calculated for the 5% of the data that was randomly omitted from refinement. of the C-E loop is responsible for forming tight interactions between BIg21 and the C-terminal AD as described in the context of the AD structure below. The conformation of the C-E interstrand loop is stabilized by three internal hydrogen bonds, a conformation that is unique to BIg21 among the structurally characterized BIg's of InvE and InvA [ Fig. 4(E-G) ].
The adhesion domain (AD)
The InvE-AD forms a compact domain of 132 residues with a molecular weight of 14.6 kDa. The core structure of the adhesion domain is made up of a globular a/b fold and can be divided into three subsections. The first is a lasso-shaped loop structure (V2661-A2677, orange), which we termed the "adaptor ring," since it forms a ring-shaped platform that connects BIg21 with the two residual subsections in the AD [ Fig. 5(A,B) ]. These two residual subsections are the "C-type lectin-like domain" (CTLD, E2678-R2689, and F2713-L2795, green) and the "wedge module" (P2690-M2712, magenta), which is inserted between strand b1 and helix a1 of the CTLD. While the function of the "adaptor ring" appears to be to stabilize the overall rod-shaped structure and to link the BIg21 to AD, the function of the "wedge module" is at this stage less clear. In contrast to the BIg20-BIg21 interface, BIg21 and the "adaptor ring" span a significantly larger contact area interface of 561 Å 2 . A total of 29 residues from both the domains (15 from BIg21, 14 from "adaptor ring") contribute to the interface thus providing several contacts including five salt bridges [ Fig. 5 (C), Supporting Information Table SI] . A Tryptophan residue (W2673) present in the "adaptor ring" is clamped between two Arginines, one from the C-E' interstrand loop and one from the A-A' loop of BIg21, stabilizing the interaction between the two domains by forming a highly rigid unit as also seen in the SAXS envelopes and high stability of a degradation fragment comprising BIg21-AD in the proteolysis experiment (Supporting Information  Fig. S5 ). As mentioned before, the "adaptor ring" appears to play an important role in linking the BIg21 and the CTLD/"wedge module." In line with such function, the interface between the "adaptor ring" and the CTLD/"wedge module" covers an area of 583 Å 2 and is thus substantially larger than the BIg20-BIg21 interface and similar to the size of BIg21-"adaptor ring" interface (Supporting Information Table SI) . Residues in the "adaptor ring" mediate a large number of hydrogen-bonds, hydrophobic, and electrostatic contacts, including a large number of water-mediated contacts, thereby generating a substantial network of interactions to stabilize the CTLD/"wedge module" conformation and form a tight link to BIg21 [ Fig. 5(D) ].
Homology to C-type lectin-like domains
As mentioned above, the adhesion domain contains a CTLD. Interestingly though, the CTLD is not solely forming the adhesion domain, but rather the "adaptor ring," "C-type lectin-like domain" and "wedge module" together form the globular adhesion domain of InvE. Initially, lectins were identified as proteins that mediate Ca 21 -dependent carbohydrate binding. Since then, more than thousand members sharing the CTLD fold have been identified from different animal species, some of which bind carbohydrates, whereas the majority lacks carbohydratebinding activity 10 and binds lipids, proteins or yet unidentified interaction partners. The canonical CTLD fold contains two antiparallel b-sheets (b11b5 and b21b31b4) and two ahelices. The fold is often further stabilized by disulfide bridges formed by four highly conserved Cysteines between b5 and a1 as well as between b3 and b5. The so-called long loop region (LLR) is located between strands b2 and b3, and plays an important role in carbohydrate binding. CTLDs can be structurally subdivided into the canonical CTLD, which contains the LLR as well as the hallmark motif "WIGL," and into the compact CTLD, which in contrast contains a significantly shorter LLR loop. Further division into subgroups is based on the presence (long form) or absence (short form) of an N-terminal extension. 10, [16] [17] [18] In InvE, the CTLD comprises the canonical strands b1, b3, and b4. Residues usually forming strands b2 and b5 are located at the canonical position, but do not conform to the b-strand geometry and are thus shown as coil instead of being displayed as b-strands in the figures (labeled in brackets for clarity). Apart from the two canonical a-helices a1 and a2, the InvE-CTLD comprises two additional a-helices, one located after a2 and one between b4 and (b5). Because of the presence of b0 as an additional N-terminal extension, it can further be classified as a long form of CTLDs [ Fig. 5(A,B) ]. In addition, InvE lacks the hallmark "WIGL" motif and its LLR only comprises less than eight residues and is thus classified as short. Accordingly, the CTLD of InvE belongs to the compact, long form CTLD sub-group. Furthermore, in comparison to the canonical CTLD, InvE-CTLD only contains two conserved Cysteines, C2722, and C2793, that form a disulfide bridge equivalent to the canonical disulfide bridge between b5 and a1, whereas it lacks Cysteine residues forming the canonical disulfide bridge between b3 and b5.
Three dimensional alignment with DALI
Regarding the question of whether InvE might contain a Ca 21 /carbohydrate binding CTLD, the lack of a long LLR as well as of specific motifs indicative of mannose or galactose-type ligands, strongly suggests that the CTLD in InvE is not a Ca 21 /carbohydrate binding CTLD, but rather targets lipids or proteins as ligand. This is further strengthened by the search for structurally related proteins. Interestingly, a structure based search with the CTLD/"wedge module" (E2678-L2795) of InvE using the DALI server 19 resulted in the best fit with the CTLDs of Intimin from enteropathogenic E. coli (EPEC)/enterohemorrhagic E. coli (EHEC) and InvA from Y. pseudotuberculosis (Z score: 8.2 to 9.2; r.m.s.d.: 2.2-2.5 Å ) despite less than 15% sequence identity for the aligned residues (Figs. 6 and 7, Supporting Information Table SIII ). Both Intimin and InvA are 900 aa proteins, consisting of the N-terminal b-barrel domain, followed by BIg domains and the Cterminal CTLD. The crystal structure of InvA reveals four BIg domains (D1-D4) and the Cterminal CTLD (D5) [also refer to Fig. 1(B) ], while Intimin comprises three BIg domains (D0-D2) and the C-terminal CTLD (D3). 7, 20, 21 During the infection process, the CLTD of Intimin targets the translocated intimin receptor (Tir), which is exported by the bacteria and integrated into the host cell plasma membrane, 22 whereas the CTLD of InvA targets b 1 -integrins on the host cell membrane, mediating efficient cellular uptake of the pathogen.
2,23
Discussion Y. pseudotuberculosis produces different adhesins, which are not only essential for bacterial uptake, but are also needed for efficient colonization in the host. Strain IP31758 of Y. pseudotuberculosis is responsible for Far East scarlet-like fever and also leads to toxic shock syndrome, which is not commonly seen for Y. pseudotuberculosis infections. 24 A novel Invasin has recently been identified in this strain. This invasin has initially been named InvasinD, which we however renamed to InvE due to the significant difference in sequence between the InvD variant identified in Y. pseudotuberculosis strain YPIII and the one from strain IP31758, characterized in this work. So far, there has been no report on the structural and functional characterization of InvE.
In this study, we provide the first structural data for the recently identified InvE. We present the crystal structure of the two C-terminal BIg domains of InvE along with the AD. BIg1-20 domains of InvE show high sequence similarities except for the BIg21 domain, which is closest to the AD. BIg20 adopts an IgSF fold and belongs to the I1 set. Because of the high sequence identity within BIg1-20, these domains are all likely to adopt the I1 set of IgSF fold, as seen for BIg20, and to act as a linker to span a certain distance and present the ligand binding domain on the cell surface. 25 The structure of BIg21 belongs to the I2 set of IgSF with a unique modification in the C-E interstrand loop, important for its interaction with AD. Structural and sequence difference in the last BIg domain suggests a special role in bacterial pathogenicity along with the AD, as seen with InvA where D4-D5 domain interface spans significantly larger area required to form a superdomain necessary to bind b 1 -integrins. 7 On the basis of the high stability and structural data, we conclude that BIg21 and AD form a functional superdomain as well, necessary to target the host receptor.
A subsection in the AD of InvE belongs to the CTLD family by virtue of its overall topology; however, it is evolutionarily distinct from the major Ctype lectin domains. While the arrangement of secondary structure elements is reminiscent of CTLDs, InvE-CTLD lacks the ability to coordinate Ca 21 , and motifs such as EPN, QPD, and WND that are responsible for the specificity of carbohydrate recognition are also absent, giving rise to the notion that the InvE-CTLD is not a carbohydrate binding domain. However, the CTLD fold that InvE resembles respresents the core of many proteins with a wide range of functions including adhesion, signaling and cell-cell recognition, 10 which hampers the functional assignment of InvE-AD on the basis of its structural features. A structural comparison reveals Structure-based alignment of the CTLD/"wedge module" of InvE and the CTLD of InvA using the DALI server. 19 Small and capital letters correspond to structurally nonaligned and aligned residues, respectively. Gaps in the sequences are depicted by a dash, residues conserved in the two sequences are linked with a vertical bar, the conserved Cysteines forming the disulfide-bridge are shown in red. For InvE, secondary structure elements are shown in the respective color code as used in Figure 3 (A). Secondary structure elements were labeled according to the canonical CTLD nomenclature.
similarities to the CTLDs of InvA and Intimin, including a conserved disulfide bridge present in all three proteins. In InvA, the integrin binding site is formed by polar and charged residues located on helix a1 and the subsequent loop of the CTLD 7 [ Fig.   6(A,B) ], whereas InvE-CTLD lacks the cluster of polar residues required for integrin binding and contains mainly hydrophobic residues [ Fig. 6(C) ], excluding b 1 -integrins as potential target of InvE. The structural superposition of the EPEC IntiminTir structure (PDB ID-1F02) with the CTLD/"wedge module" of InvE results in steric clashes and in addition InvE-CTLD lacks the short helix that is involved in Tir binding in Intimin 20 [ Fig. 7(A-C) ], which in turn suggests that the surface of InvE-CTLD is incompatible with Tir-binding. Therefore, apart from the lack of a Tir-related protein in the genus Yersinia, also the structural superposition excludes Tir as a potential interaction partner. While superposition of the three molecules via the BIg domains would allow for a direct analysis of differences in the orientation of the adhesion domains, the differences in the structures of the BIg domains preceding the adhesion domains of InvE, InvA, and Intimin hampered an accurate superposition. We instead used the CTLD as common domain for an accurate superposition [ Fig. 8(A-C) ], in order to determine the tilt of the CTLD/adhesion domain relative to the BIg-stalk. InvE is exposed on the bacterial surface, where the elongated rod composed of the BIg domains is presumably oriented perpendicular to the bacterial surface [ Fig. 8(D) ]. We therefore 19 Small and capital letters correspond to structurally non-aligned and aligned residues, respectively. Gaps in the sequences are depicted by a dash, residues conserved in the two sequences are linked with a vertical bar, the conserved Cysteines forming the disulfide-bridge are shown in red. For InvE, secondary structure elements are shown in the respective color code as used in Figure 3 (A). Secondary structure elements were labeled according to the canonical CTLD nomenclature. subsequently used the information on the tilt angles obtained from the superposition of the CTLDs to display the differences between the orientation of the adhesion domains/CTLDs of InvE, InvA, and Intimin with the BIg-stalks arranged parallel to each other [ Fig. 8(D,E) ]. In comparison to InvE-CTLD, the CTLDs in InvA and Intimin are tilted by 658 and 448 respective to the BIg domains of the rod shaped molecule. Notably, while the "adaptor ring" in InvE links the CTLD with BIg21 as described above, the CTLDs in InvA and Intimin are directly linked to the preceding BIg domain [ Fig. 8(E) ]. Apart from the tilt, we determined the dihedral angle between the CTLDs (using the N-and C-terminal residues of helix a1) and the preceding BIg (using the structurally conserved strands G and E to define the axis of the BIg), showing that InvE-CTLD is rotated by approx. 1148 (1278 to 2878) and 1038 (1278 to 2768) around the axis of the rod shaped molecule in comparison to InvA-CTLD and Intimin-CTLD, respectively [ Fig. 8(F,G) ]. Thus, the presence of the "adaptor ring" and "wedge module" in InvE result in an overall different orientation of InvE-CTLD in regard to the BIg domains and the bacterial surface, as well as in regard to the host target cell/molecule. In that context, the unique insertion of the "wedge module" within the CTLD might additionally contribute to a highly specific interaction surface required for targeting a distinct host-cell factor. Thus, despite the overall structural similarity of the adhesion domain of InvE to InvA and Intimin, it appears that the adhesion domain of InvE has evolved from a CTLD, and that the acquired insertions and modifications are likely to be functionally relevant in the context of targeting a distinct, yet unidentified interaction partner, such as a lipid or protein, on the host cell surface to promote adhesion and contribute to virulence. In summary, this work presents the first highresolution structural information of the recently identified InvE. This data provides novel insights into the architecture of invasin-family proteins, which may in the future facilitate the experimental determination of the exact roles for InvE in virulence or colonization and aid the development of preventive therapies against Yersinia infections.
Materials and Methods
The Supporting Information contains a detailed description of the protein expression, and purification, as well as of the SAXS sample preparation and data processing, phasing and refinement statistics.
Cloning of InvE
InvE (Uniprot ID-A0A0U1R0I0) expression constructs were amplified by PCR from the genomic DNA of Y. pseudotuberculosis IP31758 using KOD Hot Start DNA Polymerase (Novagen). The PCR fragment was digested with NotI-HF (NEB), KpnI (NEB) and cloned into a modified pCOLA Duet vector with an Nterminal 6xHis tag followed by a TEV protease cleavage site (MGHHHHHHVDENLYFQGGGR).
Protein expression and purification
Protein was expressed in E. coli strain Rosetta2 (DE3) (Invitrogen) in Terrific Broth (TB) media supplemented with 30 mg mL 21 Kanamycin and 34 mg mL 21 Chloramphenicol. Expression was induced by addition of isopropyl-b-D-1-thiogalactopyranoside (IPTG) (Carbosynth-EI05931) to a final concentration of 0.1 mM at an optical density at 600 nm (OD 600 ) of 0.5-0.6. Bacteria were cultured for 20 h at 188C, 130 rpm. After cell harvesting by centrifugation and lysis, InvE was purified by affinity chromatography on Ni-sepharose gravity (GE Healthcare), followed by cleavage of the affinity-tag by addition of TEV-protease and subsequent purification by size-exclusion chromatography on a HiLoad 16/60 Superdex 200 column (GE Healthcare) in buffer containing 20 mM HEPES pH 7.4, 200 mM NaCl and 5 mM DTT. Purified InvE was concentrated to 20 mg mL 21 , aliquots were frozen in liquid N 2 and stored at 2808C. For the purification of InvE mutants and SeMet-derivative, an equivalent procedure was applied.
Crystallization and structure determination of InvE
InvE2448 (K2646A) (without tag) was crystallized in 0.12 M MgCl 2 , 0.1 M TRIS pH 8.5, and 26% PEG8000 solution. The crystals were grown in sitting drop at 48C by mixture of 0.2 lL of concentrated protein with 0.2 lL of crystallization solution. For cryoprotection, the crystallization solution was supplemented with additional 10% PEG 400. The native data set (k 5 1Å ) was collected to 1.7 Å at the Swiss Light Source (SLS) at X06DA/PXIII beamline. Since Molecular Replacement failed, SeMet-labeled variant of InvE2448 (K2646A) was purified and crystallized for anomalous phasing methods. SeMet-labeled InvE crystals grew under the same condition as the native crystals. Data for the SeMet crystals (k 5 0.97927 Å ) were collected to 2.3 Å at SLS at X06DA/PXIII beamline. Data from five individual datasets collected at different kappa angles and crystal translations were merged to obtain high redundancy data for phasing. Phases were calculated using Phenix-Autosol. 26 An initial model was automatically built using Phenix-autobuild 27 and then manually rebuilt in WinCoot, 28 followed by refinement in Phenixrefine. 29 Figures were generated with PyMOL (www.
pymol.org).
SAXS data collection
Small-angle X-ray scattering (SAXS) data were measured for InvE2448 at BM29 of the ESRF in Grenoble, France. InvE2448 was prepared in a buffer consisting of 20 mM HEPES pH 7.4, 200 mM NaCl and 5 mM DTT at a protein concentration of 1 mg mL 21 . For buffer-scattering subtraction, identical buffer sample was prepared. All the data were processed using tools in the ATSAS software package. 30 Using UCSF Chimera, 31 the X-ray structure of InvE2448 was fitted in the SAXS envelope.
